← Back to Search

Behavioral Intervention

Contingency Management for Substance Use Disorder

N/A
Waitlist Available
Research Sponsored by Oregon Social Learning Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 12 to 17 years
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will help researchers understand what causes change in adolescent substance abuse treatment, so that future treatments can be more effective.

Who is the study for?
This trial is for teens aged 12 to 17 with a substance use disorder. A parent or guardian must be available to participate. It's not specified who can't join, but typically those with health issues that could interfere might be excluded.
What is being tested?
The study compares two treatments for teen substance abuse: Standard Contingency Management (CM) and an enhanced version (CM+). The goal is to find out which elements are most effective in improving outcomes during and after treatment.
What are the potential side effects?
Since the interventions involve behavioral therapy techniques rather than medications, typical medical side effects aren't expected. However, participants may experience emotional or psychological discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 12 and 17 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Changes from Baseline scores compared to 12 months post-Baseline Youth Urine Drug/Alcohol Screens (measured at 0, 2, 4, 6, 9, & 12 months).
Secondary study objectives
Changes from Baseline scores compared to 12 months post-Baseline Parent Contingency Management (CM) Adherence (measured at 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, & 12 months).
Changes from Baseline scores compared to 12 months post-Baseline Parent Management (measured at 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, & 12 months).
Changes from Baseline scores compared to 12 months post-Baseline Peer Relations (measured at 0, 2, 4, 6, 9, & 12 months).
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Enhanced Contingency Management (CM+)Experimental Treatment1 Intervention
This group will receive an enhanced CM protocol for adolescent substance abuse that targets parenting more intensely.
Group II: Standard Contingency Management (CM)Active Control1 Intervention
This group will receive standard CM for adolescent substance abuse.

Find a Location

Who is running the clinical trial?

Oregon Social Learning CenterLead Sponsor
35 Previous Clinical Trials
10,645 Total Patients Enrolled
~17 spots leftby Nov 2025